• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Juno Lighting

Juno Lighting

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Juno Therapeutics Announces Complete Response and Corresponding Early Survival Data for JCAR014 in Patients with Ibrutinib-Refractory CLL

    Juno Therapeutics Announces Complete Response and Corresponding Early Survival Data for JCAR014 in Patients with Ibrutinib-Refractory CLL

  2. UPDATE: Juno Therapeutics plummets 30% in pre-market trade after two patient deaths

    UPDATE: Juno Therapeutics plummets 30% in pre-market trade after two patient deaths

  3. UPDATE: Analysts say Juno's stock tumbles shouldn't spill over to Bluebird, Kite Pharma shares

    UPDATE: Analysts say Juno's stock tumbles shouldn't spill over to Bluebird, Kite Pharma shares

  4. BioPharm Insight Releases American Society of Hematology’s 2016 Annual Meeting (ASH) Preconference Report

    BioPharm Insight Releases American Society of Hematology’s 2016 Annual Meeting (ASH) Preconference Report

  5. MARKET SNAPSHOT: Dow On Track For Another Record Close; Biotech Weighs On Nasdaq

    MARKET SNAPSHOT: Dow On Track For Another Record Close; Biotech Weighs On Nasdaq

  6. UPDATE: Dow on track for another record close; biotech weighs on Nasdaq

    UPDATE: Dow on track for another record close; biotech weighs on Nasdaq

  7. UPDATE: Dow, S&P 500 notch third straight record close

    UPDATE: Dow, S&P 500 notch third straight record close

  8. MARKET SNAPSHOT: Dow, S&P 500 Notch Third Straight Record Close

    MARKET SNAPSHOT: Dow, S&P 500 Notch Third Straight Record Close

  9. News Highlights: Top Equities Stories Of The Day

    News Highlights: Top Equities Stories Of The Day

  10. Stocks Hit Fresh High

    Stocks Hit Fresh High

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.